Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Totaligent ( (TGNT) ) has shared an update.
On March 4, 2026, Totaligent, Inc. amended a previously signed binding letter of intent with Aetherium Medical that outlines terms for an acqui-hire in which Totaligent would acquire Aetherium’s team, business plan, intellectual property, and related assets in exchange for equity. The amendment pushes the target dates for negotiating and signing definitive agreements, as well as closing the transaction, from March 5, 2026, to April 10, 2026.
The extension preserves the binding exclusivity period through April 10, 2026, or an earlier date specified in the original letter, ensuring that Aetherium remains committed to Totaligent while negotiations and due diligence continue. Other than the new timeline, all existing terms and conditions of the original letter of intent remain in effect, underscoring both parties’ ongoing intent to complete the strategic acqui-hire.
More about Totaligent
Totaligent, Inc. is a company pursuing an acqui-hire of Aetherium Medical, a business focused on medical-related intellectual property, know-how, and associated assets. The proposed transaction would see Totaligent issue equity in exchange for Aetherium’s team, business plan, and related assets, signaling a strategic move to expand its capabilities in the medical sector.
Average Trading Volume: 105,875
Technical Sentiment Signal: Hold
Current Market Cap: $4.74M
Learn more about TGNT stock on TipRanks’ Stock Analysis page.